US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ceribell

18.92

-0.0800-0.42%

Volume:165.35K

Turnover:3.12M

Market Cap:712.17M

PE:-12.94

High:18.99

Open:18.90

Low:18.62

Close:19.00

52wk High:24.33

52wk Low:10.01

Shares:37.64M

Float Shares:22.16M

Volume Ratio:0.59

T/O Rate:0.75%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4617

EPS(LYR):-1.4617

ROE:-30.83%

ROA:-17.33%

PB:4.58

PE(LYR):-12.94

Loading ...

Overview Company News Filings

Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference

CeriBell Is Maintained at Buy by Canaccord Genuity

CeriBell Price Target Maintained With a $30.00/Share by BTIG

Ceribell Inc. Director Rebecca B. Robertson Reports Disposal of Common Shares

Ceribell Inc : TD Cowen Raises Target Price to $29 From $20

THOMSON REUTERS

BUZZ-Ceribell jumps on FDA clearance of brain monitoring device

Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

Ceribell Inc. President and CEO Xingjuan Chao Reports Disposal of Common Shares

Ceribell Inc. Senior VP Finance David Foehr Reports Disposal of Common Shares

Director Rebecca B. Robertson Reports Disposal of Ceribell Inc. Common Shares

Ceribell CEO Xingjuan Chao Reports Disposal of Common Shares

Ceribell Unveils AI EEG Platform Targeting Acute Care Seizure Detection

Ceribell Gains FDA Clearance for Seizure Detection Algorithm

Ceribell’s Strategic Expansion and Growth Potential with FDA Clearance for Clarity Algorithm

Ceribell, Inc.: Buy Rating Affirmed on Market Expansion and Technological Advancements

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

Ceribell, Inc. Poised for Growth: Buy Rating Affirmed Amid Market Expansion and Strategic Initiatives

Ceribell Inc. Chief Technology Officer Raymond Woo Reports Disposal of Common Shares

Ceribell Inc. to Join Canaccord Genuity MedTech Forum

Bank of America Securities Reaffirms Their Buy Rating on Ceribell, Inc. (CBLL)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CBLL/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBLL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","market":"US","secType":"STK","nameCN":"Ceribell","latestPrice":18.92,"timestamp":1774382400000,"preClose":19,"halted":0,"volume":165349,"delay":0,"changeRate":-0.004210526315789384,"floatShares":22161715,"shares":37641229,"eps":-1.461658,"marketStatus":"Pre-Mkt","change":-0.08,"latestTime":"03-25 07:12:45 EDT","open":18.9,"high":18.99,"low":18.62,"amount":3119100.0783,"amplitude":0.019474,"askPrice":27.13,"askSize":100,"bidPrice":11.01,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.461658,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774445400000},"marketStatusCode":1,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":18.92,"postHourTrading":{"tag":"盘后","latestPrice":18.92,"preClose":18.92,"latestTime":"16:10 EDT","volume":3577,"amount":67676.84,"timestamp":1774383004457,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5904174863599531,"impliedVol":0.2976,"impliedVolPercentile":0.084},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","floatShares":22161715,"roa":"-17.33%","roe":"-30.83%","lyrEps":-1.461658,"volumeRatio":0.5904174863599531,"shares":37641229,"dividePrice":0,"high":18.99,"amplitude":0.019474,"preClose":19,"low":18.62,"week52Low":10.01,"pbRate":"4.58","psRate":"8.00","week52High":24.33,"institutionHeld":0,"latestPrice":18.92,"eps":-1.461658,"divideRate":0,"volume":165349,"delay":0,"ttmEps":-1.461658,"open":18.9,"prevYearClose":21.93,"prevWeekClose":18.5,"prevMonthClose":18.67,"prevQuarterClose":21.93,"fiveDayClose":19.5,"twentyDayClose":19.9,"sixtyDayClose":21.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBLL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-24","symbol":"CBLL","fiscalQuarterEnding":"2025/12","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-11-04","symbol":"CBLL","fiscalQuarterEnding":"2025/09","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-08-05","symbol":"CBLL","fiscalQuarterEnding":"2025/06","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2025-02-25","symbol":"CBLL","fiscalQuarterEnding":"2024/12","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-12","symbol":"CBLL","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBLL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBLL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1761019200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBLL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBLL","date":"2026-03-24","current":-12.944204,"percent":0.645429,"low":-31.439367,"twenty":-22.739323,"median":-14.40515,"eighty":-9.646392,"high":-7.72164,"avg":-16.25833,"sd":6.319154,"marketCap":715183351},"quantilePoints":[{"date":"2024-10-11","current":-17.636997,"twenty":-17.222009,"median":-16.599526,"eighty":-15.977044,"marketCap":578317118},{"date":"2024-10-18","current":-27.492965,"twenty":-27.233597,"median":-26.455495,"eighty":-19.29695,"marketCap":901494331},{"date":"2024-10-25","current":-28.702676,"twenty":-28.6853,"median":-27.456654,"eighty":-26.040507,"marketCap":941160750},{"date":"2024-10-31","current":-28.246561,"twenty":-28.615797,"median":-28.219411,"eighty":-26.455495,"marketCap":926204733},{"date":"2024-11-08","current":-31.439367,"twenty":-28.963313,"median":-28.463759,"eighty":-26.486619,"marketCap":1030896848},{"date":"2024-11-15","current":-27.13588,"twenty":-29.27825,"median":-28.458329,"eighty":-27.13588,"marketCap":981043460},{"date":"2024-11-22","current":-25.000572,"twenty":-28.963313,"median":-28.246561,"eighty":-25.93676,"marketCap":903845676},{"date":"2024-11-29","current":-28.528199,"twenty":-28.754803,"median":-28.246561,"eighty":-26.043953,"marketCap":1031379984},{"date":"2024-12-06","current":-28.022837,"twenty":-28.754803,"median":-28.33145,"eighty":-26.11912,"marketCap":1013109620},{"date":"2024-12-13","current":-28.934471,"twenty":-29.290749,"median":-28.463759,"eighty":-26.390638,"marketCap":1046067924},{"date":"2024-12-20","current":-26.486932,"twenty":-29.217263,"median":-28.434619,"eighty":-26.480394,"marketCap":957582042},{"date":"2024-12-27","current":-26.239205,"twenty":-29.058794,"median":-28.293244,"eighty":-26.474169,"marketCap":948625981},{"date":"2025-01-03","current":-25.624843,"twenty":-28.959703,"median":-28.107549,"eighty":-26.162518,"marketCap":926414949},{"date":"2025-01-10","current":-22.810668,"twenty":-28.950325,"median":-27.629083,"eighty":-25.703081,"marketCap":824674096},{"date":"2025-01-17","current":-19.966767,"twenty":-28.888112,"median":-27.428293,"eighty":-25.067954,"marketCap":721858516},{"date":"2025-01-24","current":-22.860214,"twenty":-28.702676,"median":-27.180566,"eighty":-24.06912,"marketCap":826465309},{"date":"2025-01-31","current":-23.583576,"twenty":-28.691816,"median":-26.734658,"eighty":-23.038577,"marketCap":852617007},{"date":"2025-02-07","current":-22.404397,"twenty":-28.676835,"median":-26.675204,"eighty":-22.810668,"marketCap":809986156},{"date":"2025-02-14","current":-21.700853,"twenty":-28.676835,"median":-26.471057,"eighty":-22.741305,"marketCap":784550943},{"date":"2025-02-21","current":-22.89985,"twenty":-28.628005,"median":-26.224342,"eighty":-22.412324,"marketCap":827898278},{"date":"2025-02-28","current":-21.066166,"twenty":-28.554982,"median":-26.070751,"eighty":-22.392506,"marketCap":852231734},{"date":"2025-03-07","current":-19.700766,"twenty":-28.530515,"median":-25.634752,"eighty":-21.924596,"marketCap":796994492},{"date":"2025-03-14","current":-18.973735,"twenty":-28.528199,"median":-25.33748,"eighty":-21.562126,"marketCap":767582454},{"date":"2025-03-21","current":-17.971851,"twenty":-28.50271,"median":-25.099663,"eighty":-21.066166,"marketCap":727051231},{"date":"2025-03-28","current":-17.581737,"twenty":-28.470275,"median":-24.772663,"eighty":-20.685126,"marketCap":711269162},{"date":"2025-04-04","current":-16.606451,"twenty":-28.455071,"median":-23.826348,"eighty":-20.087337,"marketCap":671813989},{"date":"2025-04-11","current":-9.885848,"twenty":-28.423651,"median":-23.117849,"eighty":-19.576639,"marketCap":399931979},{"date":"2025-04-17","current":-12.847169,"twenty":-28.370492,"median":-23.028668,"eighty":-18.81521,"marketCap":519732232},{"date":"2025-04-25","current":-13.733792,"twenty":-28.283907,"median":-22.880032,"eighty":-18.236951,"marketCap":555600571},{"date":"2025-05-02","current":-14.434225,"twenty":-28.213982,"median":-22.800759,"eighty":-17.779392,"marketCap":583936558},{"date":"2025-05-09","current":-13.718069,"twenty":-28.090607,"median":-22.74626,"eighty":-17.175663,"marketCap":613348596},{"date":"2025-05-16","current":-14.219225,"twenty":-27.868255,"median":-22.414306,"eighty":-16.62773,"marketCap":635755756},{"date":"2025-05-23","current":-13.952463,"twenty":-27.601859,"median":-22.343922,"eighty":-15.355632,"marketCap":623828559},{"date":"2025-05-30","current":-13.758454,"twenty":-27.480147,"median":-22.032807,"eighty":-14.513655,"marketCap":615154234},{"date":"2025-06-06","current":-14.146471,"twenty":-27.447869,"median":-21.770217,"eighty":-14.377951,"marketCap":632502885},{"date":"2025-06-13","current":-14.696163,"twenty":-27.425113,"median":-21.443217,"eighty":-14.356933,"marketCap":657080139},{"date":"2025-06-20","current":-14.388982,"twenty":-27.372387,"median":-21.160809,"eighty":-14.341496,"marketCap":643345791},{"date":"2025-06-27","current":-15.593453,"twenty":-27.171629,"median":-21.066166,"eighty":-14.347335,"marketCap":697198894},{"date":"2025-07-03","current":-15.30244,"twenty":-27.13588,"median":-20.739674,"eighty":-14.354429,"marketCap":684187406},{"date":"2025-07-11","current":-13.548278,"twenty":-26.734658,"median":-20.627807,"eighty":-14.324313,"marketCap":605757048},{"date":"2025-07-18","current":-12.626736,"twenty":-26.734658,"median":-20.117479,"eighty":-14.18689,"marketCap":564554003},{"date":"2025-07-25","current":-12.432727,"twenty":-26.675204,"median":-19.774312,"eighty":-13.960546,"marketCap":555879678},{"date":"2025-08-01","current":-11.640525,"twenty":-26.675204,"median":-19.115595,"eighty":-13.895877,"marketCap":520459516},{"date":"2025-08-08","current":-9.334238,"twenty":-26.486932,"median":-18.789911,"eighty":-13.847375,"marketCap":461232717},{"date":"2025-08-15","current":-8.748066,"twenty":-26.486619,"median":-18.335366,"eighty":-13.685701,"marketCap":432268182},{"date":"2025-08-22","current":-8.666447,"twenty":-26.455495,"median":-18.12701,"eighty":-13.418939,"marketCap":428235146},{"date":"2025-08-29","current":-8.881624,"twenty":-26.239205,"median":-17.874322,"eighty":-13.305767,"marketCap":438867696},{"date":"2025-09-05","current":-9.148741,"twenty":-26.215423,"median":-17.581737,"eighty":-13.228417,"marketCap":452066725},{"date":"2025-09-12","current":-8.577408,"twenty":-26.146865,"median":-17.156157,"eighty":-13.014824,"marketCap":423835470},{"date":"2025-09-19","current":-9.319398,"twenty":-26.082843,"median":-17.03203,"eighty":-12.764159,"marketCap":460499438},{"date":"2025-09-26","current":-8.384491,"twenty":-25.963558,"median":-16.477891,"eighty":-12.584701,"marketCap":414302838},{"date":"2025-10-03","current":-8.762906,"twenty":-25.703081,"median":-15.884467,"eighty":-12.282371,"marketCap":433001462},{"date":"2025-10-10","current":-9.512316,"twenty":-25.628807,"median":-15.577755,"eighty":-11.873335,"marketCap":470032069},{"date":"2025-10-17","current":-9.638454,"twenty":-25.624843,"median":-15.30244,"eighty":-9.836369,"marketCap":476264944},{"date":"2025-10-24","current":-9.601355,"twenty":-25.394953,"median":-15.09338,"eighty":-9.596903,"marketCap":474431745},{"date":"2025-10-31","current":-8.39933,"twenty":-25.313698,"median":-14.946758,"eighty":-9.518252,"marketCap":415036117},{"date":"2025-11-07","current":-8.17419,"twenty":-25.220553,"median":-14.611284,"eighty":-9.381726,"marketCap":428826176},{"date":"2025-11-14","current":-8.831802,"twenty":-25.040208,"median":-14.477903,"eighty":-9.310494,"marketCap":463325168},{"date":"2025-11-21","current":-9.644978,"twenty":-24.865809,"median":-14.44798,"eighty":-9.268943,"marketCap":505985211},{"date":"2025-11-28","current":-11.999654,"twenty":-24.796445,"median":-14.40515,"eighty":-9.30159,"marketCap":629513859},{"date":"2025-12-05","current":-13.541154,"twenty":-24.588354,"median":-14.360689,"eighty":-9.32385,"marketCap":710382463},{"date":"2025-12-12","current":-14.432112,"twenty":-24.227665,"median":-14.357559,"eighty":-9.331037,"marketCap":757123032},{"date":"2025-12-19","current":-15.096795,"twenty":-23.777794,"median":-14.397066,"eighty":-9.334083,"marketCap":791992981},{"date":"2025-12-26","current":-15.146293,"twenty":-23.440885,"median":-14.432112,"eighty":-9.352046,"marketCap":794589679},{"date":"2026-01-02","current":-15.506919,"twenty":-23.205049,"median":-14.461736,"eighty":-9.3795,"marketCap":813508481},{"date":"2026-01-09","current":-16.313024,"twenty":-23.101995,"median":-14.491529,"eighty":-9.392114,"marketCap":855797568},{"date":"2026-01-16","current":-16.150389,"twenty":-23.036595,"median":-14.696163,"eighty":-9.441085,"marketCap":847265559},{"date":"2026-01-23","current":-16.044323,"twenty":-23.028668,"median":-14.714956,"eighty":-9.482636,"marketCap":841701206},{"date":"2026-01-30","current":-14.446254,"twenty":-22.959304,"median":-14.757383,"eighty":-9.512316,"marketCap":757864946},{"date":"2026-02-06","current":-13.675505,"twenty":-22.89985,"median":-14.696163,"eighty":-9.519736,"marketCap":717430644},{"date":"2026-02-13","current":-14.09977,"twenty":-22.860214,"median":-14.634849,"eighty":-9.564255,"marketCap":739688058},{"date":"2026-02-20","current":-14.35433,"twenty":-22.820577,"median":-14.538179,"eighty":-9.564255,"marketCap":753042507},{"date":"2026-02-27","current":-13.664784,"twenty":-22.802741,"median":-14.505155,"eighty":-9.576127,"marketCap":729863430},{"date":"2026-03-06","current":-12.607683,"twenty":-22.776977,"median":-14.473796,"eighty":-9.596903,"marketCap":673401586},{"date":"2026-03-13","current":-12.938908,"twenty":-22.755178,"median":-14.446254,"eighty":-9.631034,"marketCap":691092964},{"date":"2026-03-20","current":-13.41108,"twenty":-22.743287,"median":-14.422673,"eighty":-9.643673,"marketCap":716312587},{"date":"2026-03-24","current":-13.389938,"twenty":-22.739323,"median":-14.40515,"eighty":-9.646392,"marketCap":715183351}],"updateTime":1774435329973},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBLL\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2595710618","title":"Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2595710618","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595710618?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:05","pubTimestamp":1767128700,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., Dec.  30, 2025  (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/30/3211600/0/en/Ceribell-to-Participate-in-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU1989772923.USD","LU1732800096.USD","LU0128526141.USD","LU1244550221.USD","LU0320765646.SGD","LU1720051108.HKD","LU0971096721.USD","BK4534","LU0158827948.USD","LU0098860793.USD","LU2111349929.HKD","LU1989772840.SGD","LU2357305700.SGD","LU2028103732.USD","BK4082","BK4581","LU1791710582.SGD","LU0106261372.USD","LU0234570918.USD","LU0029874061.USD","BK4588","LU1244550577.SGD","LU1732799900.SGD","IE00BZ1G4Q59.USD","BK4585","BK4516","LU0225283273.USD","LU0267386448.USD","LU0795875169.SGD","LU2089283258.USD","XBI","LU1074936037.SGD","IE00BKVL7J92.USD","LU0006306889.USD","LU0912757837.SGD","LU0528227936.USD","LU0557290698.USD","BK4137","XLV","LU1548497426.USD","LU0158827781.USD","CBLL","BK4504","HCSG","LU2023251221.USD","LU2089284900.SGD","LU1363072403.SGD","LU2271345857.HKD","LABU"],"gpt_icon":0},{"id":"2592894830","title":"CeriBell Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2592894830","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592894830?lang=en_us&edition=fundamental","pubTime":"2025-12-18 04:06","pubTimestamp":1766001960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBLL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2025 15:06 ET (20:06 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2591648890","title":"CeriBell Price Target Maintained With a $30.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2591648890","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591648890?lang=en_us&edition=fundamental","pubTime":"2025-12-15 18:49","pubTimestamp":1765795740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBLL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 15, 2025 05:49 ET (10:49 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2590534419","title":"Ceribell Inc. Director Rebecca B. Robertson Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590534419","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590534419?lang=en_us&edition=fundamental","pubTime":"2025-12-11 02:03","pubTimestamp":1765389816,"startTime":"0","endTime":"0","summary":"Rebecca B. Robertson, Director at Ceribell Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL4tGhxm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ceribell Inc. Director Rebecca B. Robertson Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2590284533","title":"Ceribell Inc : TD Cowen Raises Target Price to $29 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2590284533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590284533?lang=en_us&edition=fundamental","pubTime":"2025-12-10 00:34","pubTimestamp":1765298043,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF0XS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2590033342","title":"BUZZ-Ceribell jumps on FDA clearance of brain monitoring device","url":"https://stock-news.laohu8.com/highlight/detail?id=2590033342","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590033342?lang=en_us&edition=fundamental","pubTime":"2025-12-09 22:43","pubTimestamp":1765291399,"startTime":"0","endTime":"0","summary":"BUZZ-Ceribell jumps on FDA clearance of brain monitoring device** Shares of medical device maker Ceribell CBLL.O rise 10.5% to $22.33** Co says the U.S. FDA cleared its screening and monitoring device to assist in diagnosing patients at risk for both seizures and delirium** Delirium is a potential indicator for life-threatening conditions and is defined as a mental state characterized by confusion, disorientation, and reduced awareness of surroundings** Ceribell's device uses an AI-powered software algorithm to analyze brain activity that is associated with delirium ** Up to last close, stock down 21.9% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nL4N3XF19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2590349375","title":"Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349375","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590349375?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:00","pubTimestamp":1765285200,"startTime":"0","endTime":"0","summary":"Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to address long unmet need in delirium monitoringSUNNYVALE, Calif., Dec.  09,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/09/3202289/0/en/Ceribell-Receives-FDA-510-k-Clearance-for-First-of-its-Kind-Delirium-Monitoring-Solution.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034390439.USD","LU2637428348.USD","CMS","LU0949170772.SGD","LU1894683348.USD","CBLL","NTAP","ESE","LU0942090050.USD","LU0545039389.USD","BK4170","LU2346227817.USD","LU0203345920.USD","BK4585","LU0868494617.USD","BK4208","LU1894683264.USD","LU1003077747.HKD","LU0203347892.USD","SG9999001440.SGD","IE00B19Z6F94.USD","BK4161","LU0868494708.USD","LU0553294199.USD","LU2500361329.USD","LU0661504455.SGD","LU0738911758.USD","BK4588","BK4082"],"gpt_icon":0},{"id":"2590506013","title":"Ceribell Inc. President and CEO Xingjuan Chao Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590506013","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590506013?lang=en_us&edition=fundamental","pubTime":"2025-12-09 02:02","pubTimestamp":1765216941,"startTime":"0","endTime":"0","summary":"Xingjuan  Chao, President and CEO of Ceribell Inc., reported a disposal of common shares of Ceribell Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL9XJmV3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ceribell Inc. President and CEO Xingjuan Chao Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2589848207","title":"Ceribell Inc. Senior VP Finance David Foehr Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589848207","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589848207?lang=en_us&edition=fundamental","pubTime":"2025-12-06 06:35","pubTimestamp":1764974153,"startTime":"0","endTime":"0","summary":"David Foehr, Senior VP, Finance and PAO of Ceribell Inc., reported a disposal of common shares of Ceribell Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL9RsFPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ceribell Inc. Senior VP Finance David Foehr Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2589345018","title":"Director Rebecca B. Robertson Reports Disposal of Ceribell Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589345018","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589345018?lang=en_us&edition=fundamental","pubTime":"2025-12-05 03:16","pubTimestamp":1764875804,"startTime":"0","endTime":"0","summary":"Rebecca B. Robertson, a director of Ceribell Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL1gnql5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Rebecca B. Robertson Reports Disposal of Ceribell Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2588025028","title":"Ceribell CEO Xingjuan Chao Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588025028","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588025028?lang=en_us&edition=fundamental","pubTime":"2025-12-04 02:34","pubTimestamp":1764786871,"startTime":"0","endTime":"0","summary":"Xingjuan  Chao, President and CEO of Ceribell Inc., has reported a disposal of common shares of Ceribell Inc., according to a recent SEC Form 4 filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL59t4XL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ceribell CEO Xingjuan Chao Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2588847047","title":"Ceribell Unveils AI EEG Platform Targeting Acute Care Seizure Detection","url":"https://stock-news.laohu8.com/highlight/detail?id=2588847047","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588847047?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:49","pubTimestamp":1764773387,"startTime":"0","endTime":"0","summary":"Ceribell Inc. has released a corporate presentation detailing recent developments in its AI-powered point-of-care EEG platform, designed for the detection and management of serious neurological conditions in acute care settings. The presentation highlights a U.S. annual addressable market estimated at over $2 billion and reports third-quarter 2025 revenue of $22.6 million, representing a 31% year-over-year increase. As of the end of the third quarter, Ceribell has 615 active accounts and achieved an 88% gross margin. The platform targets the diagnosis of both visible and non-convulsive seizures, particularly in critically ill patients where such conditions are often underdiagnosed. The content also addresses the limitations of conventional EEG systems in acute care and emphasizes the importance of timely seizure detection and intervention. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artific","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL3bBqql:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2586918544","title":"Ceribell Gains FDA Clearance for Seizure Detection Algorithm","url":"https://stock-news.laohu8.com/highlight/detail?id=2586918544","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586918544?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:59","pubTimestamp":1764003588,"startTime":"0","endTime":"0","summary":"Ceribell, Inc. ( ($CBLL) ) has shared an update. On November 24, 2025, Ceribell, Inc. announced that the FDA granted 510(k) clearance for its Clari...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceribell-gains-fda-clearance-for-seizure-detection-algorithm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceribell-gains-fda-clearance-for-seizure-detection-algorithm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2585493617","title":"Ceribell’s Strategic Expansion and Growth Potential with FDA Clearance for Clarity Algorithm","url":"https://stock-news.laohu8.com/highlight/detail?id=2585493617","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585493617?lang=en_us&edition=fundamental","pubTime":"2025-11-24 22:55","pubTimestamp":1763996136,"startTime":"0","endTime":"0","summary":"William Blair analyst Brandon Vazquez has maintained their bullish stance on CBLL stock, giving a Buy rating today. Brandon Vazquez has given his B...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribells-strategic-expansion-and-growth-potential-with-fda-clearance-for-clarity-algorithm-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribells-strategic-expansion-and-growth-potential-with-fda-clearance-for-clarity-algorithm-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2585493655","title":"Ceribell, Inc.: Buy Rating Affirmed on Market Expansion and Technological Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2585493655","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585493655?lang=en_us&edition=fundamental","pubTime":"2025-11-24 22:55","pubTimestamp":1763996128,"startTime":"0","endTime":"0","summary":"In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on Ceribell, Inc., with a price target of $20.00. Josh Jennings has...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribell-inc-buy-rating-affirmed-on-market-expansion-and-technological-advancements-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribell-inc-buy-rating-affirmed-on-market-expansion-and-technological-advancements-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2585462641","title":"Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates","url":"https://stock-news.laohu8.com/highlight/detail?id=2585462641","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585462641?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:00","pubTimestamp":1763989200,"startTime":"0","endTime":"0","summary":"Becomes the first and only FDA-cleared seizure detection algorithm for pre-term neonates through adults enabling rapid bedside detection, diagnosis, and treatment of non-convulsive seizures SUNNYVALE,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193418/0/en/Ceribell-Receives-FDA-510-k-Clearance-for-Use-of-Clarity-Algorithm-for-Neonates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2584267957","title":"Ceribell, Inc. Poised for Growth: Buy Rating Affirmed Amid Market Expansion and Strategic Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2584267957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584267957?lang=en_us&edition=fundamental","pubTime":"2025-11-18 03:45","pubTimestamp":1763408718,"startTime":"0","endTime":"0","summary":"William Blair analyst Brandon Vazquez has maintained their bullish stance on CBLL stock, giving a Buy rating on November 7. Brandon Vazquez has giv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribell-inc-poised-for-growth-buy-rating-affirmed-amid-market-expansion-and-strategic-initiatives-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribell-inc-poised-for-growth-buy-rating-affirmed-amid-market-expansion-and-strategic-initiatives-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2583515842","title":"Ceribell Inc. Chief Technology Officer Raymond Woo Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583515842","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583515842?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:51","pubTimestamp":1763059901,"startTime":"0","endTime":"0","summary":"Raymond Woo, Chief Technology Officer of Ceribell Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL2RGfTp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ceribell Inc. Chief Technology Officer Raymond Woo Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2581201708","title":"Ceribell Inc. to Join Canaccord Genuity MedTech Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2581201708","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581201708?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:09","pubTimestamp":1762463382,"startTime":"0","endTime":"0","summary":"Ceribell Inc., a medical technology company focused on neurological conditions, will participate in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on November 20, 2025. CFO Scott Blumberg will represent the company at the event. A live and archived webcast of the presentation will be available on the Ceribell website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via GlobeNewswire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLbVdpKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BKPKM429.USD","LU2210149790.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","BK4082","CBLL","IE00B3QW5Z07.USD","BK4585","LU2210150020.SGD"],"gpt_icon":0},{"id":"2581110775","title":"Bank of America Securities Reaffirms Their Buy Rating on Ceribell, Inc. (CBLL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581110775","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581110775?lang=en_us&edition=fundamental","pubTime":"2025-11-05 22:16","pubTimestamp":1762352189,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Travis Steed reiterated a Buy rating on Ceribell, Inc. today and set a price target of $26.00. Steed covers the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-reaffirms-their-buy-rating-on-ceribell-inc-cbll-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-reaffirms-their-buy-rating-on-ceribell-inc-cbll-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAC","CBLL"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":85,"code":"91000000","status":"200"}]}}